Detalhe da pesquisa
1.
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
Br J Cancer
; 121(7): 584-592, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434988
2.
The Rare Extragonadal Omental Teratoma: A Case Report.
J Minim Invasive Gynecol
; 24(6): 1046-1048, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662988
3.
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).
Gynecol Oncol
; 143(3): 532-538, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717490
4.
Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study.
Anticancer Res
; 42(4): 2017-2022, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347023
5.
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients.
Front Oncol
; 12: 818613, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35463308
6.
Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
Int J Gynecol Pathol
; 30(6): 597-604, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21979598
7.
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
J Ovarian Res
; 13(1): 53, 2020 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366278
8.
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients.
Front Oncol
; 10: 1287, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850397
9.
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.
Sci Rep
; 7(1): 10528, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874808
10.
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.
Cancer Lett
; 388: 320-327, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017893
11.
A phase II study of liposomal doxorubicin in recurrent epithelial ovarian carcinoma.
Tumori
; 90(6): 556-61, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15762356
12.
Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.
Int J Radiat Oncol Biol Phys
; 88(5): 1180-7, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529717
13.
Prognostic factors in early-stage ovarian cancer.
Ecancermedicalscience
; 7: 325, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23781280